| Ticker: | CMPS |
| Current Price: | $9.01 |
| % Daily Change: | -1.21% |
| Volume (1,000s): | 2,618.39 |
| Average Volume (1,000s): | 4,447.55 |
| Market Cap (M): | $1,276.58 |
| 1/2/2024 Price: | $8.99 |
| Change Since Inception: | 0.22% |
COMPASS Pathways plc
33 Broadwick Street
London W1F 0DQ
United Kingdom
We are COMPASS Pathways, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. Our first clinical development programme is researching investigational COMP360 psilocybin treatment for patients with treatment-resistant depression.
We want to transform the patient experience in mental health care.